Drug dis

Accelerating Chemical Biology and early Drug Discovery by academic collaborative initiatives

  • Chair(s):

    Dr. Wolfgang Fecke
    Director General,EU-OPENSCREEN, Berlin, Germany

  • Session description:

    Leveraging EU-wide screening capability to promote academic led drug-discovery
    Professor Graeme Milligan
    Acting Vice Principal and Head of College/ Gardiner Chair of Biochemistry (Institute of Molecular Cell & Systems Biology), University of Glasgow, Glasgow, United Kingdom

    EU-OPENSCREEN - An open-access research infrastructure for chemical biology and early drug discovery
    Dr Bahne Stechmann
    Head of Operations & Scientific Strategy, EU-OPENSCREEN, Berlin, Germany

    Sourcing of compounds from the chemistry community as a model to expose them to new targets
    Professor Päivi Tammela
    Professor at the Faculty of Pharmacy & Head of the FIMM High Throughput Biomedicine Unit, University of Helsinki, Helsinki, Finland

    The Kærtor Foundation - A Galician initiative in open-innovation and public-private co-development in drug discovery
    Professor Mabel Loza
    Professor of Pharmacology & Coordinator of BioFarma Research Group,University of Santiago de Compostela, Santiago de Compostela, Spain

    Small molecule inhibitors of the production of reactive oxygen species
    Dr Elisa Sassetti
    Postdoc, Danmarks Tekniske Universitet, Kgs. Lyngby, Denmark

    Distributed, Open Chemistry Towards New Medicines on a Planetary Scale
    Professor Matthew Todd
    Professor of Drug Discovery, UCL School of Pharmacy, London, United Kingdom

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

03 Jul 2023

Time

9:45 am - 11:30 am

Speakers

Leave A Comment